Decentralized clinical trials gained a foothold in the pharmaceutical industry amidst the COVID-19 pandemic and will continue to be used once the pandemic ends, according to panelists at BIO 2020.

The United States recorded 41 new measles cases last week, bringing 2019’s total number of cases to 981 in the worst outbreak of the disease since 1992, federal health officials said.

Allergan Plc’s Vraylar won U.S. regulatory approval to treat depressive episodes of bipolar I disorder, expanding the scope of treatment to a full spectrum of symptoms related to the condition.

Roche named U.S. cancer expert William Pao head of the Swiss drugmaker’s Pharma Research and Early Development business after John Reed decided to leave for what it called personal reasons.

An experimental Roche drug designed to improve social interaction in people with autism scored the U.S. Food and Drug Administration’s Breakthrough Therapy Designation.

Kaspar the social robot has helped around 170 autistic children in a handful of schools and hospitals over the last 10 years. But with approximately 700,000 people in Britain on the autism spectrum, according to the National Autistic Society, the university wants Kaspar to help more people.

Vaccination skeptic Robert F. Kennedy Jr. said he would chair a presidential panel to review vaccine safety and science at U.S. President-elect Donald Trump’s request.

(Reuters Health) — Advances in genetic testing may eventually allow for more tailored care for people with an autism spectrum disorder (ASD), researchers say. “Ultimately, what we want to do is subcategorize different forms of autism so we can give specific kinds of treatments,” said study author Stephen Scherer, of the Hospital for Sick Kids […]

People with autism may be more likely to think outside the box than people without the disorder, a British study suggests. Researchers surveyed 312 people online, asking if they had autism and assessing whether they might have some traits of the disorder even if they hadn’t been formally diagnosed with it. They tested participants’ creativity […]

That’s the question Steve Silberman asks in his March 2015 TED talk about “the forgotten history of autism.” In his talk, Silberman notes that the trajectory of understanding autism as a condition and a diagnosis has not followed what science or experience might predict (disclosure: I am personally acquainted with Silberman and consider him a friend). […]